These factors promote collagen crosslinking by activating stromal cells such as CAFs [79] and upregulating lysyl oxidases (LOXs) for collagen (type I and type III) deposition and rearrangement; thus, the ECM gradually transforms into a dense fibrous tumour stroma [80,81]. Here, LOX is linked to neoplasm.